Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 101137466 | Other Grant/Funding Number | European Union |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will analyze extracellular vesicle (EV)-derived protein profiles in heart transplantated patients during the first 15 months post-transplantation to investigate, if there are distinct EV-derived proteins or protein patterns that allow early and reliable diagnosis of acute cardiac allograft rejection. Additionally, it will explore temporal changes in the EV-derived protein profile during the early postoperative period irrespective of acute allograft rejection, and will investigate, if there are correlations between EV protein markers and imaging findings.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HTx patients | This study will include patients actively listed for heart transplantation (HTx) and patients who are still hospitalized following HTx surgery. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Identification of an extracellular vesicle-derived biomarker or biomarker pattern to diagnose endomyocardial biopsy-proven acute cellular or antibody-mediated cardiac allograft rejection | Change of the level of at least one EV-derived biomarker in the blood plasma of cardiac allograft recipients with endomyocardial biopsy-proven acute cellular or antibody-mediated cardiac allograft rejection compared to those with no rejection at the time of blood sampling. | From entrollment to the end of study participation at 15 months |
Not provided
Not provided
Inclusion Criteria:
Subject is either on the heart transplant waiting list or is still hospitalised following HTx surgery.
Age of subject is ≥ 18 years.
Subject is female or male.
Capacity to consent.
Signed written informed consent.
For female subjects:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients within the first year after heart transplantation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Laurenz Kopp Fernandes | Contact | +49 (0)30 4593 2154 | laurenz.koppfernandes@dhzc-charite.de |
| Name | Affiliation | Role |
|---|---|---|
| Felix Schoenrath, Prof | Charité Universitaetsmedizin Berlin | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Deutsches Herzzentrum der Charité, Department vor cardio-thoracic and vascular surgery | Recruiting | Berlin | State of Berlin | 13353 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
blood plasma